Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roche Holdings ADR RHHBY

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue... see more

Recent & Breaking News (OTCQX:RHHBY)

Halozyme, Ventana Enter Into Global Agreement To Collaboratively Develop Companion Diagnostic For Cancer Treatment

PR Newswire May 27, 2015

Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

PR Newswire May 26, 2015

Genentech's Investigational Medicine Alectinib Shrank Tumors in Nearly Half of People With Specific Type of Lung Cancer

Business Wire May 13, 2015

Genentech's Investigational Immunotherapy MPDL3280A Doubled the Likelihood of Survival Compared with Chemotherapy in People with a Specific Type of Lung Cancer

Business Wire May 13, 2015

Xenon Pharmaceuticals Reports First Quarter 2015 Financial Results and Provides Corporate Update

GlobeNewswire May 12, 2015

Roche Receives FDA Approval for cobas® KRAS Mutation Test

PR Newswire May 11, 2015

Pivotal Data for Genentech Medicines in Lung and Blood Cancers to Be Presented at ASCO

Business Wire May 11, 2015

Genentech Announces New STEM Education Initiative to Support South San Francisco Schools

Business Wire May 4, 2015

Bina Technologies and AstraZeneca Announce Collaborative Agreement for Global Deployment of Bina's Genomic Management Solution

Business Wire April 21, 2015

OTC Markets Group Announces First Quarter 2015 Performance of OTCQX and OTCQB Indexes, OTCM ADR Index and OTCQX30 Index and Quarterly Rebalancing

PR Newswire April 16, 2015

Ventana Medical Systems, Inc. and Astellas Pharma join forces to leverage novel companion diagnostic tests for targeted cancer treatments

PR Newswire April 14, 2015

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

PR Newswire April 13, 2015

Ariosa's Harmony(TM) Prenatal Test shown to be superior to conventional pregnancy screening for Down syndrome (Trisomy 21) in largest clinical trial

Canada NewsWire April 2, 2015

Roche introduces thermal shift assay application for LightCycler 1536 instrument

PR Newswire March 31, 2015

Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche

PR Newswire March 19, 2015

Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich

PR Newswire March 19, 2015

Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark

PR Newswire March 16, 2015

Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate Update

GlobeNewswire March 12, 2015

Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium

PR Newswire March 3, 2015

FDA Grants Genentech's Cobimetinib Priority Review for Use in Combination with Zelboraf (Vemurafenib) in Advanced Melanoma

Business Wire February 19, 2015